Guardant Health, Inc.
Price Action
Technical Summary
EMERGING TRENDGuardant Health, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 92), indicating clear outperformance against the broad market. Earnings contraction of 10% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $128.47 | +0.28% | ABOVE |
| 50 SMA | $106.63 | +20.82% | ABOVE |
| 100 SMA | $101.20 | +27.31% | ABOVE |
| 150 SMA | $102.50 | +25.69% | ABOVE |
| 200 SMA | $94.23 | +36.72% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is GH in an uptrend right now?
GH has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is GH overbought or oversold?
GH's RSI (14) is 65. The stock is in neutral territory, neither overbought nor oversold.
Is GH outperforming the market?
GH has a Relative Strength (RS) Rating of 92 out of 99. Yes, GH is a market leader, outperforming 92% of all stocks over the past 12 months.
Where is GH in its 52-week range?
GH is trading at $128.83, which is 95% of its 52-week high ($135.00) and 93% above its 52-week low ($40.35).
How volatile is GH?
GH has a Beta of 0.95 and 52-week volatility of 58%. It's less volatile than the S&P 500 - generally more stable.